ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

35,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 1442

$3.13M Total Retail Price of All Prescriptions

Rank: 1 out of 1442

1,302 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,302 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

2% of this provider’s 1,302 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 33,751 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$89 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 2,122 2,010 1 2
ATENOLOL 1,874 1,774 10 2 11
AMLODIPINE BESYLATE 1,615 1,556 3 3
LOSARTAN POTASSIUM 1,553 1,465 4 13
EVISTA 1,381 1,351 10 5 73
ATORVASTATIN CALCIUM 911 886 6 4
METOPROLOL SUCCINATE 831 808 7 1
DIOVAN 726 722 8 19
OMEPRAZOLE 662 646 9 21
JANUVIA 632 612 10 45
PLAVIX 616 601 11 14
METFORMIN HCL ER 612 588 12 71
CLOPIDOGREL 594 571 13 12
ALLOPURINOL 536 516 14 47
METOPROLOL TARTRATE 506 486 15 6
ZOLPIDEM TARTRATE 466 450 16 25
LOVASTATIN 466 454 16 53
LEVOTHYROXINE SODIUM 435 427 18 22
LIDODERM 434 420 19 76
RANITIDINE HCL 431 429 20 64
PRAVASTATIN SODIUM 427 399 21 20
AZITHROMYCIN 426 410 22 56
FUROSEMIDE 422 411 23 5
LOVAZA 416 373 24 37
DIGOXIN 371 362 25 15
WARFARIN SODIUM 355 335 26 9
POTASSIUM CHLORIDE 346 339 27 33
LISINOPRIL 338 321 28 7
TAMSULOSIN HCL 333 298 29 38
METFORMIN HCL 305 298 30 26
PRADAXA 277 277 31 27
CLONIDINE HCL 276 266 32 66
BENICAR 269 269 33 61
DONEPEZIL HCL 268 265 34 62
LIPITOR 267 249 35 24
NEXIUM 263 261 36 34
ALENDRONATE SODIUM 241 237 37 46
GLIMEPIRIDE 233 222 38 67
LOSARTAN-HYDROCHLOROTHIAZIDE 225 211 39 30
PRANDIN 223 217 40 177
AMMONIUM LACTATE 219 210 41 156
XARELTO 211 203 42 74
CRESTOR 207 199 43 10
GLYBURIDE-METFORMIN HCL 199 193 R 44 121
FLUTICASONE PROPIONATE 198 193 45 99
FENOFIBRATE 186 168 46 82
ADVAIR DISKUS 182 182 47 79
HYDROCORTISONE VALERATE 181 179 48 185
TRILIPIX 181 181 48 104
POLYETHYLENE GLYCOL 3350 179 179 50 154
FINASTERIDE 169 160 51 87
FELODIPINE ER 155 155 52 112
GABAPENTIN 151 146 53 55
ISOSORBIDE MONONITRATE ER 150 137 54 17
CLOTRIMAZOLE-BETAMETHASONE 140 134 55 118
FAMOTIDINE 139 132 56 70
TRIAMTERENE-HCTZ 135 125 57 50
HYDROCHLOROTHIAZIDE 134 131 58 16
PATADAY 132 127 59 258
SYNTHROID 128 128 60 40
DOXAZOSIN MESYLATE 123 123 61 69
PROAIR HFA 119 118 62 123
NITROSTAT 115 104 63 44
NIFEDIPINE ER 115 110 63 39
MECLIZINE HCL 113 111 65 83
CARVEDILOL 112 106 66 8
DIOVAN HCT 112 112 66 35
SINGLE USE SWAB 111 111 68 235
CELEBREX 110 106 69 138
CIPROFLOXACIN HCL 109 106 70 103
EXFORGE 109 109 70 80
ENALAPRIL MALEATE 108 108 72 23
ZETIA 107 107 73 31
LANTUS SOLOSTAR 104 100 74 147
TRICOR 103 103 75 100
MELOXICAM 103 100 75 92
TRIAMCINOLONE ACETONIDE 102 102 77 199
MULTAQ 100 100 78 89
PATANOL 98 87 79 232
AMOX TR-POTASSIUM CLAVULANATE 97 88 80 166
SINGULAIR 96 96 81 93
WELCHOL 95 95 82 143
SERTRALINE HCL 93 93 83 58
PROCTOZONE-HC 93 93 83 286
MICARDIS 88 88 85 126
NAMENDA 87 87 86 91
AZOR 87 77 86 133
LANTUS 82 82 88 139
ACTOS 77 77 89 110
DILTIAZEM 24HR CD 76 76 90 59
RAMIPRIL 72 65 91 18
LACTULOSE 71 70 92 148
NATEGLINIDE 68 68 93 221
VERAPAMIL ER 66 66 94 77
CLOBETASOL PROPIONATE 66 66 94 190
GLYBURIDE 66 66 R 94 105
CARBIDOPA-LEVODOPA 65 63 97 170
NASONEX 65 65 97 200
ALCOHOL SWABS 63 63 99 324
AMOXICILLIN 60 60 100 129
ERYTHROMYCIN 59 59 101 333
PEN NEEDLE 59 52 101 218
SPIRONOLACTONE 59 59 101 28
BETAMETHASONE VALERATE 56 51 104 340
VOLTAREN 56 55 104 137
FEXOFENADINE HCL 55 47 106 344
AVODART 54 54 107 145
NIASPAN 53 46 108 57
PANTOPRAZOLE SODIUM 53 53 108 63
PROPRANOLOL HCL 53 51 108 116
METOLAZONE 53 53 108 113
SPIRIVA 50 50 112 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.